Opioid system in depression

被引：6

作者：

Matussek, N

机构：

来源：

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2003年 / 6卷 / 04期

关键词：

D O I：

10.1017/S1461145703003808

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：443 / 443

页数：1

相关论文

共 5 条

[1] BUPRENORPHINE TREATMENT OF REFRACTORY DEPRESSION
BODKIN, JA
ZORNBERG, GL
LUKAS, SE
COLE, JO
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (01) : 49 - 57
[2] REGIONALLY SELECTIVE INCREASES IN MU-OPIOID RECEPTOR DENSITY IN THE BRAINS OF SUICIDE VICTIMS
GROSSISSEROFF, R
DILLON, KA
ISRAELI, M
BIEGON, A
[J]. BRAIN RESEARCH, 1990, 530 (02) : 312 - 316
[3] Another marker for different types of depression
Lichtigfeld, FJ
Gillman, MA
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (01) : 91 - 92
[4] INVESTIGATIONS WITH THE SPECIFIC MU-OPIATE RECEPTOR AGONIST FENTANYL IN DEPRESSIVE PATIENTS - GROWTH-HORMONE, PROLACTIN, CORTISOL, NORADRENALINE AND EUPHORIC RESPONSES
MATUSSEK, N
HOEHE, M
[J]. NEUROPSYCHOBIOLOGY, 1989, 21 (01) : 1 - 8
[5] Weber M M, 1987, Sudhoffs Arch, V71, P31